From: Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Clone | Immunogen | Animal | Subclass | |
---|---|---|---|---|
HC | LC | |||
RdMab-1 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-2 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG2a | Kappa |
RdMab-3 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgM | Kappa |
RdMab-4 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-5 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-6 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG1 | Kappa |
RdMab-7 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgG1 | Lambda |
RdMab-8 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-9 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-10 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-11 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgM | Kappa |
RdMab-12 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG1 | Kappa |
RdMab-13 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgM | Kappa |
RdMab-14 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-15 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-16 | #2, RHTFSNYQHEETIYNLLKDC | Mouse | IgG1 | Kappa |
RdMab-17 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG1 | Kappa |
RdMab-18 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgG1 | Lambda |
RdMab-19 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgG1 | Lambda |
RdMab-20 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG2b | Kappa |
RdMab-21 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgM | Kappa |
RdMab-22 | #3, TRALTAESHVDTDLTKPYIC | Mouse | IgG1 | Kappa |
RdMab-23 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgM | Kappa |
RdMab-24 | #1, AFDIYNDKVAGFAKFLKTNC | Mouse | IgG1 | Lambda |